ASM Policy efforts focus on communicating the importance of the microbial science to Congress, Federal Agencies and the Public. 

Legislative Alert: Urge Congress to Pass Increased Funding Legislation for the National Institutes of Health
The ASM asks you to contact your congressional representatives to urge them to support $34.1 billion for NIH and to pass the Cures Act.  Enactment of FY 2017 appropriations legislation with $34.1 billion for NIH and of a multi-year Innovation Fund to augment the NIH appropriation would go a long way toward reversing the erosion of NIH’s purchasing power, which is nearly 20 percent lower than 2003, after adjusting for inflation.  The Cures Act includes provisions that expand efforts to combat the growing threat of drug resistant infectious diseases, an issue brought to the attention of the Presidential Transition Team by the ASM.

What's New in Public Policy?

Prev Next

December 2, 2016 - 21st Century Cures Bill Passes House

The 21st Century Cures Act passed the House of Representatives on November 30.  It authorizes $4.8 billion over a ten year period for targeted initiatives at the NIH and $500 million for the FDA.  The bill is expected to be voted on in the Senate the week of December 5. ...


Minority Microbiology Mentor Newsletter - November 2016

The November issue of the Minority Microbiology Mentor has been published by the Committee on Microbiological Issues Impacting Minorities (CMIIM)


November 10, 2016 - ASM and PASCV Comment on Transplant Virus Testing

The ASM and Pan American Society for Clinical Virology (PASCV)  comment on reclassification of tests for the measurement of virus DNA levels in transplant-associated infections.


October 26, 2016 - ASM Joins PEW, IDSA and BD in Breakpoints Letter to Senate HELP Committee

ASM, PEW, IDSA and BD sent a letter to Senate HELP Committee Chairman Alexander and Ranking Member Murray asking them to consider language to streamline the process for updating breakpoints as they work to finalize the 21st Century Cures innovation legislation. 


October 17, 2016 - ASM, AMP and PASCV Express Concerns On New Molecular Test for Zika

The ASM, the Association for Molecular Pathology (AMP) and Pan American Society for Clinical Virology (PASCV) ask for data and clarification on the rRT-PCR assay for the testing of Zika, dengue and chikungunya viruses.


Clinical Microbiology Issues Update - October 2016

The October issue of the Clinical Microbiology Issues Update has been published by the Office of Public Affairs.


e-Public Policy Update – October 2016

The Office of Public Affairs has published the October issue of the e-Public Policy Update


October 3, 2016 - White Paper on the Emergence of mcr-1 Plasmid-Mediated Colistin Resistance

The Committee on Laboratory Practices has developed a white paper to update members on colistin resistance and testing.


September 29, 2016 - Congress Passes Short-term Continuing Resolution and Funds Zika Response

The ASM Office of Public Affairs has summarized the details of the Continuing Resolution that includes funding to combat Zika.


ASM Acts to Counter Zika Virus Outbreak

A key role of a scientific association is to make the voices of its many individual members heard as a unified whole. Speaking on behalf of its 47,000 members worldwide, ASM has acted quickly to make the case to policy makers that we must take immediate and aggressive action against...